These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19934094)

  • 1. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?
    Arsov S; Graaff R; Morariu AM; van Oeveren W; Smit AJ; Busletic I; Trajcevska L; Selim G; Dzekova P; Stegmayr B; Sikole A; Rakhorst G
    Nephrol Dial Transplant; 2010 Mar; 25(3):885-91. PubMed ID: 19934094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malnutrition inflammation score is associated with coronary artery disease in hepatitis C virus-infected hemodialysis patients.
    Elsurer R; Afsar B; Sezer S; Arat Z; Ozdemir FN; Haberal M
    Eur J Clin Nutr; 2008 Dec; 62(12):1449-54. PubMed ID: 17671439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products in renal failure: an overview.
    Noordzij MJ; Lefrandt JD; Smit AJ
    J Ren Care; 2008 Dec; 34(4):207-12. PubMed ID: 19090900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients.
    Adachi T; Fukami K; Yamagishi S; Kaida Y; Ando R; Sakai K; Adachi H; Otsuka A; Ueda S; Sugi K; Okuda S
    Nephrology (Carlton); 2012 Nov; 17(8):689-94. PubMed ID: 22804770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients.
    Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Katoh T; Miyata T; Watanabe T
    Nephrol Dial Transplant; 2011 Jan; 26(1):214-20. PubMed ID: 20591816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
    Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
    Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis.
    Ocak S; Duran N; Kaya H; Emir I
    Int J Clin Pract; 2006 Jun; 60(6):670-4. PubMed ID: 16805751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress markers in hepatitis C infected hemodialysis patients.
    Köken T; Serteser M; Kahraman A; Gökçe C
    J Nephrol; 2002; 15(3):302-7. PubMed ID: 12113603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence is elevated in neovascular age-related macular degeneration.
    Mulder DJ; Bieze M; Graaff R; Smit AJ; Hooymans JM
    Br J Ophthalmol; 2010 May; 94(5):622-5. PubMed ID: 19726430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease.
    Ueno H; Koyama H; Tanaka S; Fukumoto S; Shinohara K; Shoji T; Emoto M; Tahara H; Kakiya R; Tabata T; Miyata T; Nishizawa Y
    Metabolism; 2008 Oct; 57(10):1452-7. PubMed ID: 18803952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis.
    Herrine SK; Michael B; Ma WL; Rossi S; Dunn SR; Hyslop T
    Am J Gastroenterol; 2002 Oct; 97(10):2619-22. PubMed ID: 12385449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
    Healy H; Reith D; Morgan C; Clague A; Westhuyzen J
    Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
    Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
    Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
    J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence].
    González-Michaca L; Mercado A; Gamba G
    Rev Invest Clin; 2000; 52(3):246-54. PubMed ID: 10953607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.
    Hartog JW; de Vries AP; Lutgers HL; Meerwaldt R; Huisman RM; van Son WJ; de Jong PE; Smit AJ
    Ann N Y Acad Sci; 2005 Jun; 1043():299-307. PubMed ID: 16037252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients.
    Chiu YL; Chen HY; Chuang YF; Hsu SP; Lai CF; Pai MF; Yang SY; Peng YS
    Nephrol Dial Transplant; 2008 Nov; 23(11):3685-9. PubMed ID: 18515654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.